YI vs PINC vs TDOC vs MCK

For growth investors, McKesson Corporation (MCK) is the stronger pick with 12.

4% revenue growth year-over-year, versus -10. 9% for Premier, Inc. (PINC). McKesson Corporation (MCK) offers the better valuation at 19. 2x trailing P/E (16. 7x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, McKesson Corporation (MCK) is the cheapest at 19.

2x versus Premier, Inc. at 128. 5x. On forward P/E, McKesson Corporation is actually cheaper at 16. 7x.

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +270.

4%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: MCK returned +339. 0% versus YI's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.

02β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately -11654% more volatile than MCK relative to the S&P 500. On balance sheet safety, Premier, Inc. (PINC) carries a lower debt/equity ratio of 18% versus 110% for McKesson Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 12.

4% versus -10. 9% for Premier, Inc. (PINC). On earnings-per-share growth, the picture is similar: 111, Inc. grew EPS 83. 9% year-over-year, compared to -78. 8% for Premier, Inc.. Over a 3-year CAGR, MCK leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Premier, Inc.

(PINC) is the more profitable company, earning 2. 0% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 2. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCK leads at 1. 5% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — PINC leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, McKesson Corporation (MCK) trades at 16.

7x forward P/E versus 20. 8x for Premier, Inc. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MCK: 35. 1% to $994. 86.

In this comparison, PINC (3.

0% yield), MCK (0. 4% yield) pay a dividend. YI, TDOC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Premier, Inc.

(PINC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 0% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PINC: -4. 6%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

PINC pays a dividend while YI, TDOC, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.